BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36139751)

  • 1. Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom K; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hui L; Hannan NJ
    Antioxidants (Basel); 2022 Aug; 11(9):. PubMed ID: 36139751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Pregnancy Hypertens; 2021 Aug; 25():255-261. PubMed ID: 34325289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.
    de Alwis N; Beard S; Binder NK; Pritchard N; Tong S; Kaitu'u-Lino TJ; Hannan NJ
    Pregnancy Hypertens; 2022 Dec; 30():13-20. PubMed ID: 35933758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom K; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Hui L; Tong S; Hannan NJ
    Sci Rep; 2021 Mar; 11(1):5540. PubMed ID: 33692394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.
    de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
    Sci Rep; 2021 Oct; 11(1):20670. PubMed ID: 34667209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
    Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
    Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia.
    Gibbs I; Leavey K; Benton SJ; Grynspan D; Bainbridge SA; Cox BJ
    Am J Obstet Gynecol; 2019 Jan; 220(1):110.e1-110.e21. PubMed ID: 30312585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
    Bloise E; Zhang J; Nakpu J; Hamada H; Dunk CE; Li S; Imperio GE; Nadeem L; Kibschull M; Lye P; Matthews SG; Lye SJ
    Am J Obstet Gynecol; 2021 Mar; 224(3):298.e1-298.e8. PubMed ID: 32853537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction.
    Andres F; Hannan NJ; Walker SP; MacDonald TM; Wong GP; Murphy C; Cannon P; Kandel M; Masci J; Nguyen TV; Abboud A; Idzes D; Kyritsis V; Pritchard N; Tong S; Kaitu'u-Lino TJ
    FASEB J; 2022 Dec; 36(12):e22651. PubMed ID: 36394528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
    Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
    Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora kinase mRNA expression is reduced with increasing gestational age and in severe early onset fetal growth restriction.
    Beard S; Pritchard N; Binder N; Schindler K; De Alwis N; Kaitu'u-Lino TJ; Tong S; Hannan NJ
    Placenta; 2020 Jun; 95():53-61. PubMed ID: 32452402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated placental expression at the maternal-fetal interface but diminished maternal circulatory kisspeptin in preeclamptic pregnancies.
    Matjila M; Millar R; van der Spuy Z; Katz A
    Pregnancy Hypertens; 2016 Jan; 6(1):79-87. PubMed ID: 26955777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.
    Austdal M; Silva GB; Bowe S; Thomsen LCV; Tangerås LH; Bjørge L; Bathen TF; Iversen AC
    Hypertension; 2019 Nov; 74(5):1136-1143. PubMed ID: 31495279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels.
    Lesage J; Hahn D; Léonhardt M; Blondeau B; Bréant B; Dupouy JP
    J Endocrinol; 2002 Jul; 174(1):37-43. PubMed ID: 12098661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.